Loading clinical trials...

COMPLETED

Evaluation of MyoStrain™ in Clinical Practice

NCT03825224•University of Kansas Medical Center

Summary

Evaluate MyoStrain cardiac MRI pulse sequence in Clinical practice

Detailed Description

Evaluate MyoStrain cardiac MRI pulse sequence in Clinical practice to determine how the use may alter treatment decisions and clinical outcomes in patients who are undergoing cardiac MRI.

Eligibility

Age

All ages

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients already scheduled for diagnostic testing with commercially available imaging modality (cardiac MRI)
•The patient population will include (but not limited to), those being evaluated for heart disease and heart failure that may be related to vascular disease (coronary artery disease), drug related heart failure (chemotherapy, alcohol), inflammatory systemic conditions (sarcoidosis, amyloidosis, lupus), myocarditis, and/or infectious etiologies
•Provided written informed consent

Exclusion Criteria

•Contraindication to Magnetic Resonance Imaging

Locations (1)

The University of Kansas Medical Center

Kansas City, Kansas, United States

Key Dates

Start Date

April 15, 2019

Primary Completion Date

November 15, 2019

Completion Date

November 15, 2019

Last Updated

November 19, 2019

Enrollment

ACTUAL participants

Conditions

Cardiac FailureCoronary Artery DiseaseSarcoidosisAmyloidosisLupusMyocarditisDrug Toxicity

Interventions

Diagnostic Test: Myostrain

PROCEDURE

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI

NCT05681702

Coronary Artery Disease

View study

RECRUITING

"Erectile Function After PCI in MI and Non-MI Patients"

NCT07444697

Erectile DisfunctionCoronary Artery Disease (CAD)+3 more

View study

RECRUITING

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 19, 2019Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Evaluation of MyoStrain™ in Clinical Practice

Inclusion Criteria

Exclusion Criteria

Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI

"Erectile Function After PCI in MI and Non-MI Patients"

Revascularization Strategies in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) and Severe Coronary Artery Disease

Product Surveillance Registry

Essential Pro Study ( rEPIC04E-HK )

Rheumatology Patient Registry and Biorepository